Phase II Trial Comparing ABI-007 to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified August 2010 by Celgene Corporation.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

Celgene Corporation

ClinicalTrials.gov Identifier:

NCT00274456

First received: January 10, 2006

Last updated: August 3, 2010

Last verified: August 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2013
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)